Surgical specimens from patients allow direct molecular characterization of disease in living humans2,3,4,14, and may help overcome the limitations of cell and animal disease models that do not fully recapitulate human disease15,16. Molecular analysis of human tissue could improve the selection of new drug targets and may contribute to a higher success rate of clinical trials and drug approval17. In addition, this approach offers the potential for personalized medicine, as the obtained tissue retains the unique genomic, epigenomic, metabolomic, glycomic, and proteomic fingerprint of each individual2,18,19.
High and consistent sample quality is fundamental for all molecular analysis applications. Previous studies have shown that immediate freezing after sample retrieval and avoiding repeated freeze/thaw cycles are critical for high sample qualities9,20. Long-term storage over several years at -70 °C did not significantly affect the integrity of the proteomic profile9. A standardized protocol is an important foundation to reduce bias and improve the comparability of scientific data, especially when several people (surgeons, technicians, and others) or different institutions are involved in the sampling process. Apart from the sample quality, the annotation of samples is another important factor that requires standardization to allow the correlation of molecular findings with clinical data. Our protocol relies on three essential principles to accomplish this: 1) a standardized sampling procedure for aqueous humor and vitreous liquid biopsies by an ophthalmic surgeon, 2) the immediate processing and snap-freezing of samples in the OR by laboratory personnel, and 3) a metadata annotation of each sample in a web-based database that allows researchers to quickly find samples for later experiments.
In addition to vitreous specimens20, this workflow also establishes the standardized collection of aqueous humor liquid biopsies for molecular analysis. The aqueous humor is a highly accessible, complex fluid in the anterior chamber of the eye that does not only reflect ocular diseases of the anterior but also of the posterior segment of the eye, including retinal disease18,21. Along with the fact that a high number of aqueous humor samples could be collected e.g., during cataract surgery, one of the most frequently performed surgery worldwide, these features make it an interesting source for liquid biopsies from the human eye. The standardized metadata annotation of each sample established in this workflow could also allow the correlation of proteome data with prospective clinical follow-up data. This provides the exciting opportunity to identify new prognostic biomarkers which may help to estimate the prognosis for future patients.
However, molecular analysis of human surgical specimens also has important limitations. For example, complex experimental manipulations are often only possible in animal and cell models. A solution may be to compare the molecular profile of animal or cell models with that of human disease. This strategy can identify overlapping protein biomarkers and therapeutic targets that can be validated in animals or cell models to identify the most promising candidates that correlate with human disease and are likely to succeed in clinical trials4,16.
In conclusion, our workflow establishes a practical interface between the OR and the research laboratory that allows standardized and high-throughput collection, annotation, and storing of high-quality surgical specimens for molecular downstream analysis, providing a valuable foundation for future translational research.